vimarsana.com
Home
Live Updates
Lixte Biotechnology : Termination of Material Agreement - Fo
Lixte Biotechnology : Termination of Material Agreement - Fo
Lixte Biotechnology : Termination of Material Agreement - Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO... | May 10, 2023
Related Keywords
Washington ,
United States ,
Westpark ,
California ,
Colorado ,
,
Westpark Capital Inc ,
Company Current Report On Form ,
Lixte Biotechnology Holdings Inc ,
Nasdaqstock Market ,
Securities Exchange ,
Exchange Commission On ,
Colorado Blvd Suite ,
General Instruction ,
Securities Act ,
Exchange Act ,
Purchase Common ,
Material Definitive ,
Lixte Biotechnology Holdings ,
Westpark Capital ,
Sales Agreement ,
Current Report ,
Exchange Commission ,
Securities Exchange Act ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
United ,
Securities ,
End ,
Exchange ,
Form ,
Current ,
Ursuant Lixt Us5393192027 ,